Low molecular heparin (Enoxaparin) as an alterantive treatment of acute deep venous thrombosis in gynecologic oncology patients

European Journal of Gynaecological Oncology

Volumn 17, Issue 5, 1996, Pages 365-367

  Fishman, A ^a   Altaras, M ^a   Klein, Z ^a   Aviram, R ^a   Beyth, Y ^a  

^a MEIR MEDICAL CENTER   (Israel)

Author keywords

Deep venous thrombosis; Gynecologic oncology patients; Low molecular heparin

Indexed keywords

ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; AGED; ARTICLE; BLEEDING; CLINICAL ARTICLE; DEEP VEIN THROMBOSIS; FEMALE; GYNECOLOGIC CANCER; HUMAN; PARTIAL THROMBOPLASTIN TIME; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA;

ADULT; AGED; ANTICOAGULANTS; DRUG ADMINISTRATION SCHEDULE; ENOXAPARIN; FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; MIDDLE AGED; THROMBOPHLEBITIS; TREATMENT OUTCOME;

EID: 0029823111     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Hirsh J., Levine M N.: "Low molecular weight heparin". Blood, 1992, 79, 1.
2. Planes A., Vochelle N., Mazas F., Mansat C., Zucman J. et al., "Prevention of postoperative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement". Thromb. Haemosth., 1988, 60, 407.
3. Levine M N., Hirsh J., Gent M., Turpie A. G., Leclerc J. et al. "Prevention of deep vein thrombosis after elective hip surgery. A randomized trial comparing low molecular weight heparin with standard unfractionated heparin". Ann. Intern. Med., 1991, 114, 545.
4. Haas S., Flosbach C. W.: "Prevention of post-operative thromboembolism in general surgery with enoxaparin: preliminary findings". Acta Career Scand., 1990, 556, 96.
5. Samama M., Bernard P;. Bonnardot J. P., Combe-Tamzali S., Lanson Y. et al.: "Low molecular weight heparin compared with unfractionated heparin in prevention of postoperative thrombosis". Br. J. Surg., 1988, 75, 128.
6. a activity and prothrombinase inhibition in patients treated with two different doses of enoxaparin in gynecologic surgery". Thromb. Res., 1991, 14, 29s.
7. Samama M., Combe-Tamzali S.: "Prevention of thromboembolic disease in general surgery with enoxaparin". Br. J. Clin. Prac., 1989, 43, 9s.
8. Vitoux J.-R. Fiessinger J.-N., Roncato M., Pernes J.-M., Brenot P. et al.: "Long term treatment of acute deep venous thrombosis with low-molecular-weight heparin derivative". Correspondence. J.A.M.A., 1988, 259, 1180.
9. Simonneau G., TVPENOX study group.: "Subcutaneous fixed dose of enoxaparin (E) versus intravenous adjusted dose of unfractionated heparin (UH) in the treatment of deep venous thrombosis (DVT). Thromb. Haemost., 1991, 65, 754.
10. Heut Y., Janvier G., Bendriss P. H., Winnock S., Dugrais G., Boisseau M. et al.: "Treatment of established venous thromboembolism with enoxaparin: preliminary report". Acta Chir. Scand., 1990, 556, 116.
11. Janvier G., Freyburger G., Winnock S., Dugrais G., Boisseau M. et al.: "An open trial of enoxaparin in the treatment of deep vein thrombosis of the leg". Haemostasis, 1991, 21, 161.
12. Bang C. J., Berstad A., Talstad I.: "Haemorrhagic effects of unfractionated and two low molecular weight heparins, enoxaparin and fragmin, in rats". Haemostasis, 1991, 21, 30
13. Vinazzer H., Woler M.: "A new low molecular weight heparin fragment (PK 10169): in vitro and in vivo studies". Thromb. Res., 1985, 40, 135.
14. Christiansen H. M., Lassen M. R., Borris L. C., Sorensen J. V., Rahr H. B. et al.: "Biologic tolerance of two different low molecular weight heparins". Sem. Thromb. Hemost., 1991, 17, 450.
15. Borstad E., Urdal K., Handeland G., Abildgaard U.: "Comparison of low molecular weight heparin vs. unfractionated heparin in gynecological surgery". Acta Obstet. Gynecol. Scand., 1992, 71, 471.